Cargando…
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
OBJECTIVE: To evaluate antithrombotic (AT) use in individuals with atrial fibrillation (AF) and at high risk of stroke (CHA(2)DS(2)-VASc score ≥2) and investigate whether pre-existing AT use may improve COVID-19 outcomes. METHODS: Individuals with AF and CHA(2)DS(2)-VASc score ≥2 on 1 January 2020 w...
Autores principales: | Handy, Alex, Banerjee, Amitava, Wood, Angela M, Dale, Caroline, Sudlow, Cathie L M, Tomlinson, Christopher, Bean, Daniel, Thygesen, Johan H, Mizani, Mehrdad A, Katsoulis, Michail, Takhar, Rohan, Hollings, Sam, Denaxas, Spiros, Walker, Venexia, Dobson, Richard, Sofat, Reecha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931797/ https://www.ncbi.nlm.nih.gov/pubmed/35273122 http://dx.doi.org/10.1136/heartjnl-2021-320325 |
Ejemplares similares
-
Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study
por: Shah, Anoop Dinesh, et al.
Publicado: (2016) -
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
por: Norris, Tom, et al.
Publicado: (2022) -
Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery
por: Bouri, Sonia, et al.
Publicado: (2014) -
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
por: Tomaszewski, Maciej, et al.
Publicado: (2014) -
Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand
por: Redfern, Julie, et al.
Publicado: (2014)